Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

222 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Impact of serological and PCR testing requirements on the selection of COVID-19 convalescent plasma donors.
Carter JA, Freedenberg AT, Romeiser JL, Talbot LR, Browne NJ, Cosgrove ME, Shevik ME, Generale LM, Rago MG, Caravella GA, Ahmed T, Mamone LJ, Bennett-Guerrero E; Stony Brook Medicine COVID Plasma Trial Group. Carter JA, et al. Transfusion. 2021 May;61(5):1461-1470. doi: 10.1111/trf.16293. Epub 2021 Feb 8. Transfusion. 2021. PMID: 33559248 Free PMC article. Clinical Trial.
Severe Acute Respiratory Syndrome Coronavirus 2 Convalescent Plasma Versus Standard Plasma in Coronavirus Disease 2019 Infected Hospitalized Patients in New York: A Double-Blind Randomized Trial.
Bennett-Guerrero E, Romeiser JL, Talbot LR, Ahmed T, Mamone LJ, Singh SM, Hearing JC, Salman H, Holiprosad DD, Freedenberg AT, Carter JA, Browne NJ, Cosgrove ME, Shevik ME, Generale LM, Andrew MA, Nachman S, Fries BC; Stony Brook Medicine COVID Plasma Trial Group; Stony Brook Medicine COVID Plasma Trial Group are as follows: Investigators; Principal Investigator, Critical Care; Pathology/Blood Bank; Infectious Disease; Safety Monitor; Biostatistics; Hematology; (Blood Bank; and; Pathology, Laboratory Services). Team 1 (Online Survey/In Person Scheduling); Team Leader; and; Team 2 (In Person Screening Visits); Team Leader; and; Team 3 (Patient/Recipient Screening, Plasma Administration, Data Capture); Team Leader; and; and; and; and; Team M (Antibody Testing/Randomization):; Team Leader; and; Plaque Reduction Neutralization Assay: Janet Hearing. Regulatory (Investigational New Drug [IND] and Institutional Review Board [IRB] support); (IND support); (IRB support), and; Data and Safety Monitoring Board (DSMB); and; (Chair) and; (unblinded DSMB statistician); Stony Brook Medicine COVID Plasma Trial Group and Stony Brook Medicine COVID Plasma Trial Group are as follows: Investig… See abstract for full author list ➔ Bennett-Guerrero E, et al. Among authors: carter ja. Crit Care Med. 2021 Jul 1;49(7):1015-1025. doi: 10.1097/CCM.0000000000005066. Crit Care Med. 2021. PMID: 33870923 Free PMC article. Clinical Trial.
Diribonuclease activity eliminates toxic diribonucleotide accumulation.
Kim SK, Orr MW, Turdiev H, Jenkins CC, Lormand JD, Myers TM, Burnim AA, Carter JA, Kung WC, Jiang X, Sondermann H, Winkler WC, Lee VT. Kim SK, et al. Among authors: carter ja. Cell Rep. 2024 Sep 24;43(9):114759. doi: 10.1016/j.celrep.2024.114759. Epub 2024 Sep 13. Cell Rep. 2024. PMID: 39276351 Free PMC article.
222 results